Vaidehi R. Chowdhary, MBBS, MD
Associate Professor of Medicine (Rheumatology, Allergy & Immunology)Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Clinical Chief, Rheumatology, Allergy, & Immunology
Contact Info
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Clinical Chief, Rheumatology, Allergy, & Immunology
Contact Info
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Clinical Chief, Rheumatology, Allergy, & Immunology
Contact Info
About
Titles
Associate Professor of Medicine (Rheumatology, Allergy & Immunology)
Clinical Chief, Rheumatology, Allergy, & Immunology
Biography
Vaidehi Chowdhary, MD, is a rheumatologist who treats people with autoimmune diseases, including gout, vasculitis, and different types of arthritis. She has a special interest in lupus, a complex disease in which the body attacks its own tissues and organs, causing pain, fatigue, and other symptoms.
Dr. Chowdhary, who worked at the Mayo Clinic before coming to Yale, says she became a doctor because she was inspired by the combination of science and art in medicine. “The good part is that you're never far away from people. I've learned so much from my patients—lessons of courage, lessons in resilience. It’s good to know that I can be an important part of their journey to healing,” she says. “I think rheumatologists are unique in that regard, in that they'll listen to patients, knowing that this is part of the disease. So, patients feel heard, and I think that's the first step.”
In addition to caring for patients, Dr. Chowdhary is an associate professor of rheumatology at Yale School of Medicine who participates in research into better treatment for people with rheumatologic disease. She advises anyone who has a family history or is concerned about symptoms to consult a rheumatologist. “The earlier we treat these diseases, the lesser the chance of these diseases leading to life-threatening manifestations,” she says.
Appointments
Rheumatology
Associate Professor on TermPrimary
Other Departments & Organizations
- Internal Medicine
- Rheumatology
- Rheumatology, Allergy, & Immunology
- Transition Program for Young Adults with Chronic Rheumatic Conditions
- Yale Medicine
Education & Training
- Fellow
- Mayo School of Graduate Medical Education (2008)
- Resident
- Mayo School of Graduate Medical Education (2005)
- Post-Doctoral Fellowship
- Mayo Graduate School of Medicine (2003)
- MD
- Mayo Graduate School of Medicine, Department of Immunology /Post Doctoral Fellowship (2000)
- DM
- Sanjay Gandhi Post-Graduate Institute of Medical Sciences (1998)
- MD
- Sassoon Hospitals, Byramjee Jeejeebhoy Medical College (1994)
- MBBS
- Byramjee Jeejeebhoy Medical College (1991)
Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Danielle Antin-Ozerkis, MD
Govind Rajagopalan
Abhijeet Danve, MBBS, MD, MHS
Betty Hsiao, MD
Heather Allore, PhD
Lisa Gale Suter, MD
Publications
2024
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, Khanna D, Guyatt G, Mirza R, Aggarwal R, Allen A, Assassi S, Buckley L, Chami H, Corwin D, Dellaripa P, Domsic R, Doyle T, Falardeau C, Frech T, Gibbons F, Hinchcliff M, Johnson C, Kanne J, Kim J, Lim S, Matson S, McMahan Z, Merck S, Nesbitt K, Scholand M, Shapiro L, Sharkey C, Summer R, Varga J, Warrier A, Agarwal S, Antin‐Ozerkis D, Bemiss B, Chowdhary V, D'Amico J, Hallowell R, Hinze A, Injean P, Jiwrajka N, Joerns E, Lee J, Makol A, McDermott G, Natalini J, Oldham J, Saygin D, Lakin K, Singh N, Solomon J, Sparks J, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev I. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care & Research 2024, 76: 1070-1082. PMID: 38973729, DOI: 10.1002/acr.25347.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSystemic autoimmune rheumatic diseasesInterstitial lung diseasePulmonary function testsAutoimmune rheumatic diseasesMonitoring of interstitial lung diseaseChest radiographyHigh-resolution computed tomography of the chestInterstitial lung disease risk factorsLung diseaseChest PhysiciansInterstitial lung disease progressionAmerican CollegeDevelopment of interstitial lung diseaseRheumatic diseasesAmerican College of Chest PhysiciansHigh-resolution computed tomographyMonitoring interstitial lung diseasesSurgical lung biopsyIdiopathic inflammatory myopathiesConnective tissue diseaseClinical practice guidelinesWalk test distanceGrading of RecommendationsEvidence-based recommendationsLung biopsy2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, Khanna D, Guyatt G, Mirza R, Aggarwal R, Allen A, Assassi S, Buckley L, Chami H, Corwin D, Dellaripa P, Domsic R, Doyle T, Falardeau C, Frech T, Gibbons F, Hinchcliff M, Johnson C, Kanne J, Kim J, Lim S, Matson S, McMahan Z, Merck S, Nesbitt K, Scholand M, Shapiro L, Sharkey C, Summer R, Varga J, Warrier A, Agarwal S, Antin‐Ozerkis D, Bemiss B, Chowdhary V, D'Amico J, Hallowell R, Hinze A, Injean P, Jiwrajka N, Joerns E, Lee J, Makol A, McDermott G, Natalini J, Oldham J, Saygin D, Lakin K, Singh N, Solomon J, Sparks J, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev I. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & Rheumatology 2024, 76: 1201-1213. PMID: 38973714, DOI: 10.1002/art.42860.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSystemic autoimmune rheumatic diseasesInterstitial lung diseasePulmonary function testsAutoimmune rheumatic diseasesMonitoring of interstitial lung diseaseChest radiographyHigh-resolution computed tomography of the chestInterstitial lung disease risk factorsLung diseaseChest PhysiciansInterstitial lung disease progressionAmerican CollegeDevelopment of interstitial lung diseaseRheumatic diseasesAmerican College of Chest PhysiciansHigh-resolution computed tomographyMonitoring interstitial lung diseasesSurgical lung biopsyIdiopathic inflammatory myopathiesConnective tissue diseaseClinical practice guidelinesWalk test distanceGrading of RecommendationsEvidence-based recommendationsLung biopsy2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, Khanna D, Guyatt G, Mirza R, Aggarwal R, Allen A, Assassi S, Buckley L, Chami H, Corwin D, Dellaripa P, Domsic R, Doyle T, Falardeau C, Frech T, Gibbons F, Hinchcliff M, Johnson C, Kanne J, Kim J, Lim S, Matson S, McMahan Z, Merck S, Nesbitt K, Scholand M, Shapiro L, Sharkey C, Summer R, Varga J, Warrier A, Agarwal S, Antin‐Ozerkis D, Bemiss B, Chowdhary V, D'Amico J, Hallowell R, Hinze A, Injean P, Jiwrajka N, Joerns E, Lee J, Makol A, McDermott G, Natalini J, Oldham J, Saygin D, Lakin K, Singh N, Solomon J, Sparks J, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev I. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & Rheumatology 2024, 76: 1182-1200. PMID: 38978310, DOI: 10.1002/art.42861.Peer-Reviewed Original ResearchCitationsAltmetricConceptsTreatment of interstitial lung diseaseSystemic autoimmune rheumatic diseasesInterstitial lung diseaseAutoimmune rheumatic diseasesLung diseaseChest PhysiciansInterstitial lung disease progressionAmerican CollegeProgressive interstitial lung diseaseRheumatic diseasesAmerican College of Chest PhysiciansClinical practice guidelinesGrading of RecommendationsEvidence-based recommendationsClinically relevant populationOutcome questionsPractice guidelinesSystematic literature reviewDiseasePhysiciansTreatmentGlucocorticoidTherapyRelevant populationRecommendations2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, Khanna D, Guyatt G, Mirza R, Aggarwal R, Allen A, Assassi S, Buckley L, Chami H, Corwin D, Dellaripa P, Domsic R, Doyle T, Falardeau C, Frech T, Gibbons F, Hinchcliff M, Johnson C, Kanne J, Kim J, Lim S, Matson S, McMahan Z, Merck S, Nesbitt K, Scholand M, Shapiro L, Sharkey C, Summer R, Varga J, Warrier A, Agarwal S, Antin‐Ozerkis D, Bemiss B, Chowdhary V, D'Amico J, Hallowell R, Hinze A, Injean P, Jiwrajka N, Joerns E, Lee J, Makol A, McDermott G, Natalini J, Oldham J, Saygin D, Lakin K, Singh N, Solomon J, Sparks J, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev I. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care & Research 2024, 76: 1051-1069. PMID: 38973731, DOI: 10.1002/acr.25348.Peer-Reviewed Original ResearchCitationsAltmetricConceptsTreatment of interstitial lung diseaseSystemic autoimmune rheumatic diseasesInterstitial lung diseaseAutoimmune rheumatic diseasesLung diseaseChest PhysiciansInterstitial lung disease progressionAmerican CollegeProgressive interstitial lung diseaseRheumatic diseasesAmerican College of Chest PhysiciansClinical practice guidelinesGrading of RecommendationsEvidence-based recommendationsClinically relevant populationOutcome questionsPractice guidelinesSystematic literature reviewDiseasePhysiciansTreatmentGlucocorticoidTherapyRelevant populationRecommendationsIs yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
Palacios C, Chowdhary V, Hao R, Danve A, Malinis M. Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings? PLOS ONE 2024, 19: e0306337. PMID: 38959249, PMCID: PMC11221665, DOI: 10.1371/journal.pone.0306337.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsInterferon-gamma release assayDisease-modifying antirheumatic drugsInterferon-gamma release assay testLatent tuberculosis infectionNon-endemic settingsRheumatologic diseasesRisk factorsPositive interferon-gamma release assayLatent tuberculosis infection screeningLatent tuberculosis infection diagnosisPositive IGRA testMonths of rifampinLow-risk patientsRetrospective chart reviewTNF-alpha inhibitorsTB risk factorsTargeted LTBI screeningOutpatient rheumatology clinicDisease-modifying drugsIGRA testPatient demographicsAdult patientsChart reviewAntirheumatic drugsNon-endemic areasRegional European genetic ancestry predicts type I interferon level and risk of severe viral infection
Nln I, Shum J, Ghodke-Puranik Y, Tipon R, Triese D, Amin S, Makol A, Osborn T, Chowdhary V, Thanarajasingam U, Muskardin T, Oke V, Gunnarsson I, Zickert A, Zervou M, Boumpas D, Svenungsson E, Goulielmos G, Niewold T. Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection. QJM 2024, 117: 581-588. PMID: 38530799, PMCID: PMC11389909, DOI: 10.1093/qjmed/hcae052.Peer-Reviewed Original ResearchAltmetricConceptsType I IFN levelsViral infection outcomesI interferonLupus patientsEuropean genetic ancestryInfection outcomesAnti-viral cytokinesSevere viral infectionsType I interferon levelsHost genetic factorsRisk of severe viral infectionsSevere organ failureI interferon levelsType I IFNType I interferonVirus prior to infectionViral hepatitisOrgan failureGenetic testingViral infectionI IFNOutcome dataHost defenseGenetic factorsGenetic ancestry
2023
Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs
Baker H, Fine R, Suter F, Allore H, Hsiao B, Chowdhary V, Lavelle E, Chen P, Hintz R, Suter L, Danve A. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs. Arthritis Care & Research 2023 PMID: 37382043, DOI: 10.1002/acr.25181.Peer-Reviewed Original ResearchCitationsAltmetricConceptsBest practice advisoryHepatitis B virusAutoimmune rheumatic diseasesBPA implementationSynthetic disease-modifying antirheumatic drugsDisease-modifying antirheumatic drugsHepatitis C virus infectionHepatitis B surface antigenC virus infectionUse of biologicsB surface antigenQuality improvement initiativesElectronic health recordsEligible patientsAntirheumatic drugsRheumatic diseasesRheumatology practiceSociety guidelinesB virusPractice advisoryComputerized decision support systemVirus infectionRoutine screeningPatient screeningPatients
2018
TD-08 High type I interferon activity is associated with active class III/IV lupus nephritis in european-american lupus patients independent of anti-dsDNA antibodies
Iwamoto T, Dorschner J, Jensen M, Vsetecka D, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold T. TD-08 High type I interferon activity is associated with active class III/IV lupus nephritis in european-american lupus patients independent of anti-dsDNA antibodies. 2018, a75.2-a76. DOI: 10.1136/lupus-2018-lsm.127.Peer-Reviewed Original ResearchFRI0371 Clinical characteristics and outcome of isolated lupus nephritis
Bugdayli K, Chowdhary V, Crowson C, Zand L, Alexander M, Cornell L. FRI0371 Clinical characteristics and outcome of isolated lupus nephritis. Annals Of The Rheumatic Diseases 2018, 77: 720. DOI: 10.1136/annrheumdis-2018-eular.6053.Peer-Reviewed Original ResearchConceptsExtra-renal manifestationsLupus nephritisSystemic lupus erythematosusAntinuclear antibodiesClinical manifestationsEnd-stage renal diseaseStandardised data collection formClass III nephritisPartial renal responseRenal biopsy databasePositive antinuclear antibodyAnti-dsDNA antibodiesMajority of patientsExtractable nuclear antigensImmune complex glomerulonephritisData collection formMean C3SLICC criteriaLast followMycophenolate mofetilRenal involvementRenal transplantClinical characteristicsLaboratory featuresPartial responsePS1:1 High type i interferon activity is associated with active class 3/4 lupus nephritis in european-american lupus patients independent of anti-dsdna antibodies
Iwamoto T, Dorschner J, Jensen M, Vsetecka D, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold T. PS1:1 High type i interferon activity is associated with active class 3/4 lupus nephritis in european-american lupus patients independent of anti-dsdna antibodies. 2018, a32.1-a32. DOI: 10.1136/lupus-2018-abstract.50.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
honor Attending of the Year
Other AwardYale Rheumatology FellowsDetails06/10/2020honor Senior Research Associateship
International AwardCouncil of Scientific ResearchDetails08/26/2019Indiahonor Nelson Career Development Award
National AwardMayo FoundationDetails05/01/2016United Stateshonor Department of Medicine Laureate Award
National AwardMayo ClinicDetails09/01/2015United Stateshonor Nelson Career Development Award
National AwardMayo FoundationDetails04/01/2013United States
Clinical Care
Overview
Vaidehi Chowdhary, MD, is a rheumatologist who treats people with autoimmune diseases, including gout, vasculitis, and different types of arthritis. She has a special interest in lupus, a complex disease in which the body attacks its own tissues and organs, causing pain, fatigue, and other symptoms.
Diseases like lupus can be difficult and painful, and patients express worry about how their condition will affect their lifestyles, Dr. Chowdhary says. But researchers are introducing a growing number of treatments for lupus and other rheumatologic diseases, including new medicines that target specific pathways in the immune system that cause inflammation and pain. While many medications are slow-acting, she says it’s rewarding to work with patients through the years and see them feel better over time. “You can give more patients hope, and I think that's a very powerful thing.”
Dr. Chowdhary, who worked at the Mayo Clinic before coming to Yale, says she became a doctor because she was inspired by the combination of science and art in medicine. “The good part is that you're never far away from people. I've learned so much from my patients—lessons of courage, lessons in resilience. It’s good to know that I can be an important part of their journey to healing,” she says. “I think rheumatologists are unique in that regard, in that they'll listen to patients, knowing that this is part of the disease. So, patients feel heard, and I think that's the first step.”
In addition to caring for patients, Dr. Chowdhary is an associate professor of rheumatology at Yale School of Medicine who participates in research into better treatment for people with rheumatologic disease. She advises anyone who has a family history or is concerned about symptoms to consult a rheumatologist. “The earlier we treat these diseases, the lesser the chance of these diseases leading to life-threatening manifestations,” she says.
Clinical Specialties
Fact Sheets
Rheumatoid Arthritis
Learn More on Yale MedicineLupus
Learn More on Yale MedicineDiagnosing Lupus Nephritis
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
- June 17, 2024
New Endowment To Support Innovation in Rheumatology Care and Research
- September 01, 2023
Celebrating Annette Torres: 25 Years at Yale
- August 29, 2023
New Outpatient Raynaud Treatment Saves Fingers and Toes
- August 25, 2023
Rheumatology Nursing Education Improves Patient Care
Get In Touch
Contacts
Locations
Yale Rheumatology, Allergy & Immunology
Academic Office
The Anlyan Center
300 Cedar Street, Fl 5th, Rm TACS-517
New Haven, CT 06519
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
Everyone Richard Bucala, MD, PhD - Vaidehi R. Chowdhary, MBBS, MD - Robert Schoen, MD, MBA - Linda Bockenstedt, MD - Leonard H. Calabrese, DO - Erol Fikrig, MD - Paul S. Mead, MD, MPH - John J. Ross, MD - Allen C. Steere, MD - Astrid van Tubergen, MD, PhD - Kevin Winthrop, MD, MPH - Eugene Shapiro, MD